📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

Diplomat Pharmacy plunges after warning of 'going concern' risk

Published 11/12/2019, 10:48 AM
Updated 11/12/2019, 10:51 AM
© Reuters.  Diplomat Pharmacy plunges after warning of 'going concern' risk
DPLO_old
-

(Reuters) - Diplomat Pharmacy Inc (N:DPLO) on Tuesday warned about its ability to continue as a going concern amid struggles with its pharmacy benefits management business, sending the company's shares falling more than 50% to a record low.

Flint, Michigan-based Diplomat, facing customer losses in its PBM business in the face of intense competition, earlier this year said it was reviewing options including a sale of the whole company.

The company, which started out in 1975 as a neighborhood pharmacy and also provides specialty pharmacy services, forayed into the PBM business in 2017 with back-to-back purchases of LDI Integrated Pharmacy Services and National Pharmaceutical Services.

"Strategic alternatives process seems to have transitioned to distressed sale," Baird analyst Eric Coldwell said in a client note.

"This is a very bad update as Diplomat seems to be nearing the end of its current incarnation."

The company said it may not be able to meet certain covenants in its credit agreements, which would give lenders the right to terminate funding for the company's line of credit and accelerate its debt.

Diplomat said it intends to work with its lenders to renegotiate the covenants but this uncertainty will lead to its quarterly filing with U.S. security regulators to include commentary expressing "substantial doubts" about its ability to function as a going concern.

Diplomat also said there had been interest in both the whole company and its businesses and that it was engaged in advanced discussions.

The company's stock, down 54.5% at $2.82, was the second-biggest percentage loser across U.S. exchanges in early trading.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.